デフォルト表紙
市場調査レポート
商品コード
1451879

バイオテクノロジー試薬市場レポート:技術、用途、地域別、2024-2032

Biotechnology Reagents Market Report by Technology (Life Science Reagents, Analytical Reagents), Application (Protein Synthesis and Purification, Gene Expression, DNA and RNA Analysis, Drug Testing, and Others), and Region 2024-2032

出版日: | 発行: IMARC | ページ情報: 英文 138 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
バイオテクノロジー試薬市場レポート:技術、用途、地域別、2024-2032
出版日: 2024年03月02日
発行: IMARC
ページ情報: 英文 138 Pages
納期: 2~3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界のバイオテクノロジー試薬市場規模は、2023年に854億1,010万米ドルに達しました。今後、IMARC Groupは、2024年から2032年にかけての成長率(CAGR)は7.42%を示し、2032年には1,658億1,950万米ドルに達すると予測しています。ライフサイエンス分野における研究開発(R&D)活動の発展、個別化医療や標的治療に対する需要の高まり、ゲノミクスやプロテオミクス研究の急速な進展、慢性疾患や感染症の急増などが、市場を牽引する主な要因となっています。

バイオテクノロジー試薬は、ライフサイエンス分野で極めて重要な役割を果たし、様々な研究や診断アプリケーションを促進します。試薬は、生物学的分子やシステムの単離、分析、操作を可能にするバイオテクノロジー・プロセスで使用される重要なコンポーネントです。これらは細心の製造工程を経て製造され、正確で信頼性の高い結果を提供するよう設計されており、実験や調査の進展と成功を確実なものにしています。バイオテクノロジー試薬の主な利点のひとつは、その多用途性とライフサイエンスにおける複数の分野にわたる幅広い適用性です。バイオテクノロジー試薬は、デオキシリボ核酸(DNA)、リボ核酸(RNA)、タンパク質の抽出・精製、アッセイ、バイオマーカーの検出、遺伝子発現研究の実施を可能にするため、ゲノミクス、プロテオミクス、細胞生物学、分子診断学、創薬などの様々な研究分野で活用されています。バイオテクノロジー試薬はまた、新しい治療薬、ワクチン、個別化医薬品の開発を促進し、ヘルスケアと疾病治療の進歩に貢献しています。

バイオテクノロジー試薬市場の動向:

世界のバイオテクノロジー試薬市場は、ライフサイエンス分野における研究開発(R&D)活動の増加や、個別化医療や標的治療に対する需要の高まりなど、数多くの要因によって支えられています。さらに、ゲノミクスやプロテオミクス研究の急速な進展、慢性疾患や感染症の急増が市場の成長を加速させています。このほか、バイオテクノロジーと分子生物学の技術的進歩、製薬・バイオテクノロジー産業の拡大も市場成長に弾みをつけています。さらに、ヘルスケア・インフラへの投資の急増、政府のイニシアティブ、研究プロジェクトへの資金提供なども成長を促す要因となっています。これに伴い、学術機関と業界各社との共同研究が活発化し、分子診断薬に対する認識と採用が高まっていることも、市場の成長を後押ししています。さらに、バイオインフォマティクスや計算生物学の台頭、バイオバンクやバイオリポジトリ施設の拡大も市場成長を後押ししています。その他、正確な実験結果を得るための高品質な試薬に対する需要の急増、農業における遺伝子組み換え作物(GMO)に対する需要の高まり、CRISPR/Cas9遺伝子編集などの新たな用途に向けた新規試薬の市場開拓などが、市場成長にプラスに寄与しています。

本レポートで扱う主な質問

  • 世界のバイオテクノロジー試薬市場はこれまでどのように推移してきたか?
  • 世界のバイオテクノロジー試薬市場における市場促進要因、市場抑制要因、機会は何か?
  • それぞれの促進要因、抑制要因、機会が世界のバイオテクノロジー試薬市場に与える影響は?
  • 主要な地域市場とは?
  • 最も魅力的なバイオテクノロジー試薬市場はどの国か?
  • 技術別の市場内訳は?
  • バイオテクノロジー試薬市場で最も魅力的な技術は?
  • 用途別の市場内訳は?
  • バイオテクノロジー試薬市場で最も魅力的な用途は?
  • 世界のバイオテクノロジー試薬市場の競争構造は?
  • バイオテクノロジー試薬の世界市場における主要プレーヤー/企業は?

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査目的
  • 利害関係者
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要産業動向

第5章 バイオテクノロジー試薬の世界市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳:技術別

  • ライフサイエンス試薬
    • 市場動向
    • 主要セグメント
      • PCR
      • 細胞培養
      • 血液学
      • 体外診断薬
      • その他
    • 市場予測
  • 分析試薬
    • 市場動向
    • 主要セグメント
      • クロマトグラフィー
      • 質量分析
      • 電気泳動
      • フローサイトメトリー
      • その他
    • 市場予測

第7章 市場内訳:用途別

  • タンパク質合成・精製
    • 市場動向
    • 市場予測
  • 遺伝子発現
    • 市場動向
    • 市場予測
  • DNAおよびRNA分析
    • 市場動向
    • 市場予測
  • 医薬品検査
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第8章 市場内訳:地域別

  • 北米
    • 米国
      • 市場動向
      • 市場予測
    • カナダ
      • 市場動向
      • 市場予測
  • アジア太平洋
    • 中国
      • 市場動向
      • 市場予測
    • 日本
      • 市場動向
      • 市場予測
    • インド
      • 市場動向
      • 市場予測
    • 韓国
      • 市場動向
      • 市場予測
    • オーストラリア
      • 市場動向
      • 市場予測
    • インドネシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 欧州
    • ドイツ
      • 市場動向
      • 市場予測
    • フランス
      • 市場動向
      • 市場予測
    • 英国
      • 市場動向
      • 市場予測
    • イタリア
      • 市場動向
      • 市場予測
    • スペイン
      • 市場動向
      • 市場予測
    • ロシア
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • ラテンアメリカ
    • ブラジル
      • 市場動向
      • 市場予測
    • メキシコ
      • 市場動向
      • 市場予測
    • その他
      • 市場動向
      • 市場予測
  • 中東・アフリカ地域
    • 市場動向
    • 市場内訳:国別
    • 市場予測

第9章 促進要因、抑制要因、機会

  • 市場概要
  • 促進要因
  • 抑制要因
  • 機会

第10章 バリューチェーン分析

第11章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第12章 価格分析

第13章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Agilent Technologies Inc.
    • Beckman Coulter Inc.(Danaher Corporation)
    • Becton Dickinson and Company
    • bioMerieux SA
    • Bio-Rad Laboratories Inc.
    • Illumina Inc.
    • Lonza Group AG
    • Merck KGaA
    • Meridian Bioscience Inc.(SD Biosensor)
    • PerkinElmer Inc.
    • Promega Corporation
    • Thermo Fisher Scientific Inc.
    • Waters Corporation
図表

List of Figures

  • Figure 1: Global: Biotechnology Reagents Market: Major Drivers and Challenges
  • Figure 2: Global: Biotechnology Reagents Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 4: Global: Biotechnology Reagents Market: Breakup by Technology (in %), 2023
  • Figure 5: Global: Biotechnology Reagents Market: Breakup by Application (in %), 2023
  • Figure 6: Global: Biotechnology Reagents Market: Breakup by Region (in %), 2023
  • Figure 7: Global: Biotechnology Reagents (Life Science Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 8: Global: Biotechnology Reagents (Life Science Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 9: Global: Biotechnology Reagents (Analytical Reagents) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Biotechnology Reagents (Analytical Reagents) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Biotechnology Reagents (Protein Synthesis and Purification) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Biotechnology Reagents (Protein Synthesis and Purification) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Biotechnology Reagents (Gene Expression) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Biotechnology Reagents (Gene Expression) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Biotechnology Reagents (DNA and RNA Analysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Biotechnology Reagents (DNA and RNA Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Biotechnology Reagents (Drug Testing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Biotechnology Reagents (Drug Testing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Biotechnology Reagents (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Biotechnology Reagents (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: North America: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: North America: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: United States: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: United States: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Canada: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Canada: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Asia-Pacific: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Asia-Pacific: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: China: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: China: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Japan: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Japan: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: India: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: India: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: South Korea: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: South Korea: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Australia: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Australia: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Indonesia: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Indonesia: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: Others: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: Others: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: Europe: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: Europe: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Germany: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Germany: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: France: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: France: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: United Kingdom: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: United Kingdom: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Italy: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Italy: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: Spain: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: Spain: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: Russia: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: Russia: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Others: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Others: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Latin America: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Latin America: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Brazil: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Brazil: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Mexico: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Mexico: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Others: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Others: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: Middle East and Africa: Biotechnology Reagents Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: Middle East and Africa: Biotechnology Reagents Market: Breakup by Country (in %), 2023
  • Figure 69: Middle East and Africa: Biotechnology Reagents Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Global: Biotechnology Reagents Industry: Drivers, Restraints, and Opportunities
  • Figure 71: Global: Biotechnology Reagents Industry: Value Chain Analysis
  • Figure 72: Global: Biotechnology Reagents Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biotechnology Reagents Market: Key Industry Highlights, 2023 & 2032
  • Table 2: Global: Biotechnology Reagents Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 3: Global: Biotechnology Reagents Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Biotechnology Reagents Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 5: Global: Biotechnology Reagents Market: Competitive Structure
  • Table 6: Global: Biotechnology Reagents Market: Key Players
目次
Product Code: SR112024A8220

The global biotechnology reagents market size reached US$ 85,410.1 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 165,819.5 Million by 2032, exhibiting a growth rate (CAGR) of 7.42% during 2024-2032. Increasing research and development (R&D) activities in the life sciences sector, the growing demand for personalized medicine and targeted therapies, the rapid advancements in genomics and proteomics research, and the surging prevalence of chronic and infectious diseases represent some of the key factors driving the market.

Biotechnology reagents play a pivotal role in the field of life sciences, facilitating various research and diagnostic applications. They are vital components used in biotechnology processes to enable the isolation, analysis, and manipulation of biological molecules and systems. They are made through meticulous manufacturing processes and are designed to provide accurate and reliable results, ensuring the progress and success of experiments and investigations. One of the key advantages of biotechnology reagents is their versatility and broad applicability across multiple disciplines within the life sciences. They are utilized in various research areas, such as genomics, proteomics, cell biology, molecular diagnostics, and drug discovery, as they enable scientists to extract and purify deoxyribonucleic acid (DNA), ribonucleic acid (RNA), and proteins, as well as perform assays, detect biomarkers, and conduct gene expression studies. Biotechnology reagents also facilitate the development of new therapeutic drugs, vaccines, and personalized medicines, contributing to advancements in healthcare and the treatment of diseases.

Biotechnology Reagents Market Trends:

The global biotechnology reagents market is bolstered by numerous factors, including the increasing research and development (R&D) activities in the life sciences sector and the growing demand for personalized medicine and targeted therapies. Moreover, the rapid advancements in genomics and proteomics research and the surging prevalence of chronic and infectious diseases are accelerating the market growth. Besides this, the technological advancements in biotechnology and molecular biology and the expansion of pharmaceutical and biotechnology industries are providing an impetus to the market growth. Additionally, the burgeoning investments in healthcare infrastructure and government initiatives and funding for research projects are other growth-inducing factors. In line with this, the escalating collaborations between academic institutions and industry players and growing awareness and adoption of molecular diagnostics are supporting the market growth. Furthermore, the emergence of bioinformatics and computational biology and the expansion of biobanking and biorepository facilities are augmenting the market growth. Other factors, such as the surging demand for high-quality reagents for accurate experimental results, escalating demand for genetically modified organisms (GMOs) in agriculture, and the development of novel reagents for emerging applications, such as CRISPR/Cas9 gene editing, are positively contributing to the market growth.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global biotechnology reagents market, along with forecasts at the global, regional, and country levels from 2024-2032. Our report has categorized the market based on technology and application.

Technology Insights:

Life Science Reagents

PCR

Cell Culture

Hematology

In-Vitro Diagnostics

Others

Analytical Reagents

Chromatography

Mass Spectrometry

Electrophoresis

Flow Cytometry

Others

A detailed breakup and analysis of the biotechnology reagents market based on the technology has also been provided in the report. This includes life science reagents (PCR, cell culture, hematology, In-Vitro diagnostics, and others) and analytical reagents (chromatography, mass spectrometry, electrophoresis, flow cytometry, and others).

Application Insights:

Protein Synthesis and Purification

Gene Expression

DNA and RNA Analysis

Drug Testing

Others

A detailed breakup and analysis of the biotechnology reagents market based on the application has also been provided in the report. This includes protein synthesis and purification, gene expression, DNA and RNA analysis, drug testing, and others.

Regional Insights:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America was the largest market for biotechnology reagents. Some of the factors driving the North America biotechnology reagents market included the surging applications of biotechnology in environmental monitoring and remediation, the development of novel reagents for emerging applications, such as CRISPR/Cas9 gene editing, and the expansion of the biotechnology industry.

Competitive Landscape:

The report has also provided a comprehensive analysis of the competitive landscape in the global biotechnology reagents market. Detailed profiles of all major companies have been provided. Some of the companies covered include Agilent Technologies Inc., Beckman Coulter Inc. (Danaher Corporation), Becton Dickinson and Company, bioMerieux SA, Bio-Rad Laboratories Inc., Illumina Inc., Lonza Group AG, Merck KGaA, Meridian Bioscience Inc. (SD Biosensor), PerkinElmer Inc., Promega Corporation, Thermo Fisher Scientific Inc., and Waters Corporation etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Questions Answered in This Report:

  • How has the global biotechnology reagents market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global biotechnology reagents market?
  • What is the impact of each driver, restraint, and opportunity on the global biotechnology reagents market?
  • What are the key regional markets?
  • Which countries represent the most attractive biotechnology reagents market?
  • What is the breakup of the market based on technology?
  • Which is the most attractive technology in the biotechnology reagents market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the biotechnology reagents market?
  • What is the competitive structure of the global biotechnology reagents market?
  • Who are the key players/companies in the global biotechnology reagents market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biotechnology Reagents Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Technology

  • 6.1 Life Science Reagents
    • 6.1.1 Market Trends
    • 6.1.2 Key Segments
      • 6.1.2.1 PCR
      • 6.1.2.2 Cell Culture
      • 6.1.2.3 Hematology
      • 6.1.2.4 In-Vitro Diagnostics
      • 6.1.2.5 Others
    • 6.1.3 Market Forecast
  • 6.2 Analytical Reagents
    • 6.2.1 Market Trends
    • 6.2.2 Key Segments
      • 6.2.2.1 Chromatography
      • 6.2.2.2 Mass Spectrometry
      • 6.2.2.3 Electrophoresis
      • 6.2.2.4 Flow Cytometry
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Protein Synthesis and Purification
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Gene Expression
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 DNA and RNA Analysis
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Drug Testing
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Region

  • 8.1 North America
    • 8.1.1 United States
      • 8.1.1.1 Market Trends
      • 8.1.1.2 Market Forecast
    • 8.1.2 Canada
      • 8.1.2.1 Market Trends
      • 8.1.2.2 Market Forecast
  • 8.2 Asia-Pacific
    • 8.2.1 China
      • 8.2.1.1 Market Trends
      • 8.2.1.2 Market Forecast
    • 8.2.2 Japan
      • 8.2.2.1 Market Trends
      • 8.2.2.2 Market Forecast
    • 8.2.3 India
      • 8.2.3.1 Market Trends
      • 8.2.3.2 Market Forecast
    • 8.2.4 South Korea
      • 8.2.4.1 Market Trends
      • 8.2.4.2 Market Forecast
    • 8.2.5 Australia
      • 8.2.5.1 Market Trends
      • 8.2.5.2 Market Forecast
    • 8.2.6 Indonesia
      • 8.2.6.1 Market Trends
      • 8.2.6.2 Market Forecast
    • 8.2.7 Others
      • 8.2.7.1 Market Trends
      • 8.2.7.2 Market Forecast
  • 8.3 Europe
    • 8.3.1 Germany
      • 8.3.1.1 Market Trends
      • 8.3.1.2 Market Forecast
    • 8.3.2 France
      • 8.3.2.1 Market Trends
      • 8.3.2.2 Market Forecast
    • 8.3.3 United Kingdom
      • 8.3.3.1 Market Trends
      • 8.3.3.2 Market Forecast
    • 8.3.4 Italy
      • 8.3.4.1 Market Trends
      • 8.3.4.2 Market Forecast
    • 8.3.5 Spain
      • 8.3.5.1 Market Trends
      • 8.3.5.2 Market Forecast
    • 8.3.6 Russia
      • 8.3.6.1 Market Trends
      • 8.3.6.2 Market Forecast
    • 8.3.7 Others
      • 8.3.7.1 Market Trends
      • 8.3.7.2 Market Forecast
  • 8.4 Latin America
    • 8.4.1 Brazil
      • 8.4.1.1 Market Trends
      • 8.4.1.2 Market Forecast
    • 8.4.2 Mexico
      • 8.4.2.1 Market Trends
      • 8.4.2.2 Market Forecast
    • 8.4.3 Others
      • 8.4.3.1 Market Trends
      • 8.4.3.2 Market Forecast
  • 8.5 Middle East and Africa
    • 8.5.1 Market Trends
    • 8.5.2 Market Breakup by Country
    • 8.5.3 Market Forecast

9 Drivers, Restraints, and Opportunities

  • 9.1 Overview
  • 9.2 Drivers
  • 9.3 Restraints
  • 9.4 Opportunities

10 Value Chain Analysis

11 Porters Five Forces Analysis

  • 11.1 Overview
  • 11.2 Bargaining Power of Buyers
  • 11.3 Bargaining Power of Suppliers
  • 11.4 Degree of Competition
  • 11.5 Threat of New Entrants
  • 11.6 Threat of Substitutes

12 Price Analysis

13 Competitive Landscape

  • 13.1 Market Structure
  • 13.2 Key Players
  • 13.3 Profiles of Key Players
    • 13.3.1 Agilent Technologies Inc.
      • 13.3.1.1 Company Overview
      • 13.3.1.2 Product Portfolio
      • 13.3.1.3 Financials
      • 13.3.1.4 SWOT Analysis
    • 13.3.2 Beckman Coulter Inc. (Danaher Corporation)
      • 13.3.2.1 Company Overview
      • 13.3.2.2 Product Portfolio
      • 13.3.2.3 SWOT Analysis
    • 13.3.3 Becton Dickinson and Company
      • 13.3.3.1 Company Overview
      • 13.3.3.2 Product Portfolio
      • 13.3.3.3 Financials
      • 13.3.3.4 SWOT Analysis
    • 13.3.4 bioMerieux SA
      • 13.3.4.1 Company Overview
      • 13.3.4.2 Product Portfolio
      • 13.3.4.3 Financials
      • 13.3.4.4 SWOT Analysis
    • 13.3.5 Bio-Rad Laboratories Inc.
      • 13.3.5.1 Company Overview
      • 13.3.5.2 Product Portfolio
      • 13.3.5.3 Financials
      • 13.3.5.4 SWOT Analysis
    • 13.3.6 Illumina Inc.
      • 13.3.6.1 Company Overview
      • 13.3.6.2 Product Portfolio
      • 13.3.6.3 Financials
      • 13.3.6.4 SWOT Analysis
    • 13.3.7 Lonza Group AG
      • 13.3.7.1 Company Overview
      • 13.3.7.2 Product Portfolio
      • 13.3.7.3 Financials
      • 13.3.7.4 SWOT Analysis
    • 13.3.8 Merck KGaA
      • 13.3.8.1 Company Overview
      • 13.3.8.2 Product Portfolio
      • 13.3.8.3 Financials
      • 13.3.8.4 SWOT Analysis
    • 13.3.9 Meridian Bioscience Inc. (SD Biosensor)
      • 13.3.9.1 Company Overview
      • 13.3.9.2 Product Portfolio
      • 13.3.9.3 SWOT Analysis
    • 13.3.10 PerkinElmer Inc.
      • 13.3.10.1 Company Overview
      • 13.3.10.2 Product Portfolio
      • 13.3.10.3 Financials
      • 13.3.10.4 SWOT Analysis
    • 13.3.11 Promega Corporation
      • 13.3.11.1 Company Overview
      • 13.3.11.2 Product Portfolio
    • 13.3.12 Thermo Fisher Scientific Inc.
      • 13.3.12.1 Company Overview
      • 13.3.12.2 Product Portfolio
      • 13.3.12.3 Financials
      • 13.3.12.4 SWOT Analysis
    • 13.3.13 Waters Corporation
      • 13.3.13.1 Company Overview
      • 13.3.13.2 Product Portfolio
      • 13.3.13.3 Financials
      • 13.3.13.4 SWOT Analysis

Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.